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Biology

Characterizing B-Lymphocyte Response
to Neoantigen Exposure in Early-Stage
Pancreatic Cancer
Katherine Alexander
Mentors: Samarth Hegde and David G. DeNardo
Even in its earliest stages, pancreatic ductal adenocarcinoma (PDAC) remains a highly
lethal disease, with a five-year survival rate of < 10%. This is especially puzzling, given the
known presence of neoantigens that should be acted upon by the host adaptive immune
response. These epitopes are not recognized as “self ” by the thymus, and are thus
vulnerable to immune surveillance and attack. During the course of pancreatic cancer
progression, immune surveillance is altered, even though the specific components
responsible for altering anti-tumor immune responses have not yet been identified.
Using a genetically engineered mouse model of PDAC that recapitulates human PDAC
progression and secretes chicken ovalbumin (OVA), a moderately immunogenic
epitope that models neoantigenicity, we investigated changes in the immune infiltrate in
response to neoantigen exposure in early-stage pancreatic cancer. This was done using
immunofluorescent staining and immune cell quantitation via HALO software. B cell
infiltration was correlated to both tissue transformation and tumor grade to examine
the relationship between antigen exposure and PDAC pathogenesis. Additionally, the
induction of inflammatory response was examined by comparing B cell quantitation to
granulocyte count. Our investigation revealed that infiltration of B220+ B lymphocytes
increased in early stage tumors expressing OVA and corresponded with disease stage,
progression, and inflammation, demonstrating an early host adaptive immune response
against neoantigen in pancreatic lesions. Future studies will explore these parameters in
later stage disease tissue to observe changes in the immune infiltrate and whether or not
adaptive immune activation declines over time. These findings may further support why
advances in immunotherapy have yet to yield results in treating patients with pancreatic
cancer.
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